Uncategorized -
Notification of transaction by an Officer of Millicom (Tigo)
Notification of transaction by an Officer of Millicom (Tigo) Luxembourg, March 1, 2025 – Millicom International Cellular S.A. (“Millicom” or […]
Uncategorized -
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company […]
Uncategorized -
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
– Greatly improved patient quality of life and reduced disease impact in patients with CSU and CIndU –– 82% of […]
Uncategorized -
NIO Inc. Provides February 2025 Delivery Update
13,192 vehicles were delivered in February 2025, increasing by 62.2% year-over-year 27,055 vehicles were delivered year-to-date in 2025, increasing by 48.8% […]
